摘要
多发性硬化(MS)是中枢神经系统最常见的慢性炎性脱髓鞘疾病,最常累及的部位为脑室周围白质、视神经、脊髓、脑干和小脑,病因和发病机制迄今不明。MS为缓慢进行性疾病,其治疗过程长,目前尚无完全治愈本病的药物。复发缓解型MS(RRMS)是MS最常见的类型,约占80%～85%,对其急性期和缓解期的治疗有助于减少复发,减缓疾病进展,提高患者生存质量。该文就这方面的研究进展进行综述。
Multiple sclerosis （MS） is a most common chronic inflammatory demyetinating disease of the central nervous system. The most frequently involved sites are brainal periventricular white matter, optic nerve, spinal cord,brain stem and cerebellum. Its etiology and mechansim of pathogeness are yet unclear to reseachers. MS is slowly progressive disease and the treatment for MS need a long-term process. At present, the durgs can＇ t completely cure the disease. Relapsing remitting MS（RRMS） is the most common type of MS which accounts for about 80% ~ 85%. The treatment of acute phase and remission phase of MS will help to reduce the relapsing, slow the progress of the disease and improve the quality of life of patients. The progress of researchs in this field is reviewed.
出处
《中国临床新医学》
2012年第3期274-276,共3页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词
多发性硬化:
复发缓解型MS
急性期治疗
缓解期治疗
药物
Multiple sclerosis（MS）
Relapsing remitting MS （RRMS）
Acute phasic treatment
Re-mission phasic treatment
Drugs
